Healthcare provider profile · identity verified

Kyle Crooks, D.O.

Family Practice · ROSEVILLE, CA · NPI 1750743019

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	527	185
Levothyroxine Sodium	Levothyroxine Sodium	336	98
Losartan Potassium	Losartan Potassium	294	110
Albuterol Sulfate Hfa	Albuterol Sulfate	283	98
Lisinopril	Lisinopril	265	95
Amlodipine Besylate	Amlodipine Besylate	248	94
Fluticasone Propionate	Fluticasone Propionate	195	67
Trazodone Hcl	Trazodone Hcl	193	62
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	191	35
Gabapentin	Gabapentin	181	62
Ibuprofen	Ibuprofen	139	55
Meloxicam	Meloxicam	135	45
Hydrochlorothiazide	Hydrochlorothiazide	134	49
Omeprazole	Omeprazole	130	47
Duloxetine Hcl	Duloxetine Hcl	124	42
Famotidine	Famotidine	123	53
Tamsulosin Hcl	Tamsulosin Hcl	119	48
Metoprolol Tartrate	Metoprolol Tartrate	116	43
Pantoprazole Sodium	Pantoprazole Sodium	111	40
Metformin Hcl	Metformin Hcl	104	38
Furosemide	Furosemide	101	35
Metoprolol Succinate	Metoprolol Succinate	97	38
Allopurinol	Allopurinol	93	32
Simvastatin	Simvastatin	87	31
Alvesco	Ciclesonide	86	38
Atenolol	Atenolol	85	30
Metformin Hcl Er	Metformin Hcl	84	33
Sertraline Hcl	Sertraline Hcl	71	31
Alendronate Sodium	Alendronate Sodium	67	22
Glipizide	Glipizide	67	24
Montelukast Sodium	Montelukast Sodium	63	23
Tramadol Hcl	Tramadol Hcl	62	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	60	16
Prednisone	Prednisone	59	44
Terazosin Hcl	Terazosin Hcl	58	19
Triamcinolone Acetonide	Triamcinolone Acetonide	58	35
Spiriva Respimat	Tiotropium Bromide	56	19
Diphenhydramine Hcl	Diphenhydramine Hcl	54	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	54	11
Lovastatin	Lovastatin	51	17
Acyclovir	Acyclovir	49	20
Pregabalin	Pregabalin	49	17
Pradaxa	Dabigatran Etexilate Mesylate	48	17
Baclofen	Baclofen	46	suppressed
Potassium Chloride	Potassium Chloride	46	18
Bupropion Xl	Bupropion Hcl	45	13
Doxycycline Monohydrate	Doxycycline Monohydrate	45	38
Hydralazine Hcl	Hydralazine Hcl	45	16
Alprazolam	Alprazolam	41	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	29
Ozempic	Semaglutide	40	suppressed
Jardiance	Empagliflozin	39	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	39	15
Ondansetron Odt	Ondansetron	39	11
Wixela Inhub	Fluticasone Propion/Salmeterol	39	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	38	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	38	14
Zolpidem Tartrate	Zolpidem Tartrate	37	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	12
Ondansetron Hcl	Ondansetron Hcl	36	suppressed
Citalopram Hbr	Citalopram Hydrobromide	34	12
Tizanidine Hcl	Tizanidine Hcl	33	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	31	12
Propranolol Hcl Er	Propranolol Hcl	30	11
Buspirone Hcl	Buspirone Hcl	29	suppressed
Nystatin	Nystatin	29	15
Pravastatin Sodium	Pravastatin Sodium	29	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	11
Rosuvastatin Calcium	Rosuvastatin Calcium	28	14
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	26
Cholestyramine	Cholestyramine (With Sugar)	26	suppressed
Clonazepam	Clonazepam	26	suppressed
Colchicine	Colchicine	26	15
Breyna	Budesonide/Formoterol Fumarate	25	suppressed
Cefadroxil	Cefadroxil	25	23
Lorazepam	Lorazepam	25	13
Temazepam	Temazepam	25	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	25	suppressed
Carvedilol	Carvedilol	24	suppressed
Azelastine Hcl	Azelastine Hcl	23	suppressed
Clopidogrel	Clopidogrel Bisulfate	23	suppressed
Diazepam	Diazepam	23	suppressed
Humulin N	Insulin Nph Human Isophane	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Topiramate	Topiramate	23	suppressed
Hydrocortisone	Hydrocortisone	22	15
Lactulose	Lactulose	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	19
Spironolactone	Spironolactone	22	suppressed
Lidocaine	Lidocaine	21	suppressed
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Testosterone	Testosterone	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	18	suppressed
Finasteride	Finasteride	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Eliquis	Apixaban	16	suppressed
Naloxone Hcl	Naloxone Hcl	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Fluconazole	Fluconazole	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Naproxen	Naproxen	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Nabumetone	Nabumetone	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Estradiol	Estradiol	12	suppressed
Fluorouracil	Fluorouracil	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Naratriptan Hcl	Naratriptan Hcl	12	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error